VA-MD Regional College of Veterinary Medicine, University of Maryland, College Park, MD, 20742, USA.
Sci Rep. 2018 Nov 15;8(1):16854. doi: 10.1038/s41598-018-35337-z.
Avian influenza remains an important zoonotic disease with a significant global impact. The spread of H5 highly pathogenic avian influenza (HPAI) viruses (clade 2.3.4.4) by migratory birds has caused outbreaks in wide geographic regions (Asia, Europe, and North America) with great economic losses during 2014-2015. Efficient vaccines and vaccination approaches are needed to enhance protective immunity against HPAI viruses. Although several vaccination strategies have been developed, none has been satisfactory. Our strategy has been to use avirulent vaccine strain of Newcastle disease virus (NDV) as a vaccine vector for HPAI viruses. For poultry vaccination, we previously generated a new platform of chimeric NDV vector to overcome preexisting maternal antibodies to NDV in poultry. In this study, we have generated vaccine candidates targeting H5 clade 2.3.4.4 HPAI viruses by using our chimeric NDV and conventional NDV strain LaSota vectors for a heterologous prime-boost immunization approach. Co-expression of the HA and NA proteins by our vaccine vectors induced enhanced HPAI virus specific immune responses in specific-pathogen free and broiler chickens prior to challenge. Further, these vaccine candidates efficiently protected broiler chickens from mortality, clinical signs, and shedding of homologous and heterologous H5 HPAI viruses and highly virulent NDV, thus providing a dual vaccination approach in the field.
禽流感仍然是一种重要的人畜共患病,具有重大的全球影响。H5 高致病性禽流感(HPAI)病毒(clade 2.3.4.4)通过候鸟传播,导致 2014-2015 年在亚洲、欧洲和北美等广泛地理区域爆发疫情,并造成巨大的经济损失。需要有效的疫苗和接种方法来增强对 HPAI 病毒的保护免疫。尽管已经开发了几种疫苗接种策略,但没有一种是令人满意的。我们的策略是使用无致病性的新城疫病毒(NDV)疫苗株作为 HPAI 病毒的疫苗载体。对于家禽接种,我们之前生成了一种新的嵌合 NDV 载体平台,以克服家禽中存在的针对 NDV 的预先存在的母源抗体。在这项研究中,我们使用我们的嵌合 NDV 和常规 NDV 株 LaSota 载体生成了针对 H5 clade 2.3.4.4 HPAI 病毒的疫苗候选物,用于异源初免-加强免疫接种方法。我们的疫苗载体共表达 HA 和 NA 蛋白,可在挑战前增强无特定病原体鸡和肉鸡对 HPAI 病毒的特异性免疫反应。此外,这些疫苗候选物有效地保护肉鸡免受同源和异源 H5 HPAI 病毒和高致病性 NDV 的死亡率、临床症状和排出,从而在现场提供了双重接种方法。